BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34455946)

  • 1. The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development.
    Iersel TV; Courville J; Doorne CV; Koster RA; Fawcett C
    Curr Rev Clin Exp Pharmacol; 2022; 17(1):8-17. PubMed ID: 34455946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Centric Product Development: A Summary of Select Regulatory CMC and Device Considerations.
    Algorri M; Cauchon NS; Christian T; O'Connell C; Vaidya P
    J Pharm Sci; 2023 Apr; 112(4):922-936. PubMed ID: 36739904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decentralisation in Clinical Trials and Patient Centricity: Benefits and Challenges.
    Sinha SD; Chary Sriramadasu S; Raphael R; Roy S
    Pharmaceut Med; 2024 Mar; 38(2):109-120. PubMed ID: 38453755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of health plan administrative claims data in participant recruitment for pragmatic clinical trials: An Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) example.
    Shi Q; Shambhu S; Marshall A; Rose-Kennedy E; Robertson H; Paullin M; Jones WS; Cziraky M; Haynes K
    Clin Trials; 2020 Apr; 17(2):212-222. PubMed ID: 32009464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a theory of holistic needs and the brain.
    Silton NR; Flannelly LT; Flannelly KJ; Galek K
    Holist Nurs Pract; 2011; 25(5):258-65. PubMed ID: 21832931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding socio-economic inequalities in food choice behaviour: can Maslow's pyramid help?
    van Lenthe FJ; Jansen T; Kamphuis CB
    Br J Nutr; 2015 Apr; 113(7):1139-47. PubMed ID: 25784199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maslow's hierarchy of needs: a framework for achieving human potential in hospice.
    Zalenski RJ; Raspa R
    J Palliat Med; 2006 Oct; 9(5):1120-7. PubMed ID: 17040150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients.
    de Las Heras B; Daehnke A; Saini KS; Harris M; Morrison K; Aguilo A; Chico I; Vidal L; Marcus R
    Digit Health; 2022; 8():20552076221099997. PubMed ID: 35646380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Motivation for work based on needs--considerations from the health manager's viewpoint].
    Duma O
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):528-33. PubMed ID: 14756056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-centricity in digital measure development: co-evolution of best practice and regulatory guidance.
    Aryal S; Blankenship JM; Bachman SL; Hwang S; Zhai Y; Richards JC; Clay I; Lyden K
    NPJ Digit Med; 2024 May; 7(1):128. PubMed ID: 38755349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Centricity: Design and Conduct of Clinical Trials in Orphan Diseases: Third of Three Sets of Expanded Proceedings from the 2020 ISCTM Autumn Conference on Pediatric Drug Development.
    Busner J; Pandina G; Day S; Mahableshwarkar A; Kempf L; Sheean M; Dunn J
    Innov Clin Neurosci; 2023; 20(1-3):25-31. PubMed ID: 37122576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Patient-Centered Mobile Phone App (iHeartU) With a Virtual Human Assistant for Self-Management of Heart Failure: Protocol for a Usability Assessment Study.
    Zhang L; Babu SV; Jindal M; Williams JE; Gimbel RW
    JMIR Res Protoc; 2019 May; 8(5):e13502. PubMed ID: 31124472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and challenges with decentralized trials in Neuroscience.
    Burger HU; Van de Casteele T; Rantell KR; Corey-Lisle P; Sfikas N; Abt M;
    Biom J; 2023 Dec; 65(8):e2200370. PubMed ID: 37609878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development.
    Stergiopoulos S; Michaels DL; Kunz BL; Getz KA
    Ther Innov Regul Sci; 2020 Jan; 54(1):103-116. PubMed ID: 32008233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Centricity and Pharmaceutical Companies: Is It Feasible?
    du Plessis D; Sake JK; Halling K; Morgan J; Georgieva A; Bertelsen N
    Ther Innov Regul Sci; 2017 Jul; 51(4):460-467. PubMed ID: 30227057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renovating the Pyramid of Needs: Contemporary Extensions Built Upon Ancient Foundations.
    Kenrick DT; Griskevicius V; Neuberg SL; Schaller M
    Perspect Psychol Sci; 2010 May; 5(3):292-314. PubMed ID: 21874133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gathering Structured Patient Insight to Drive the PRO Strategy in COPD: Patient-Centric Drug Development from Theory to Practice.
    Patalano F; Gutzwiller FS; Shah B; Kumari C; Cook NS
    Adv Ther; 2020 Jan; 37(1):17-26. PubMed ID: 31707715
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.